| __timestamp | Vertex Pharmaceuticals Incorporated | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 305409000 | 1643000000 |
| Thursday, January 1, 2015 | 377080000 | 1532000000 |
| Friday, January 1, 2016 | 432829000 | 1364000000 |
| Sunday, January 1, 2017 | 496079000 | 1334000000 |
| Monday, January 1, 2018 | 557616000 | 1484000000 |
| Tuesday, January 1, 2019 | 658498000 | 1638000000 |
| Wednesday, January 1, 2020 | 770456000 | 1726000000 |
| Friday, January 1, 2021 | 840100000 | 2001000000 |
| Saturday, January 1, 2022 | 944700000 | 2009000000 |
| Sunday, January 1, 2023 | 1136600000 | 2151000000 |
| Monday, January 1, 2024 | 1464300000 | 2318000000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding the financial dynamics of industry leaders is crucial. Over the past decade, Vertex Pharmaceuticals Incorporated and Zoetis Inc. have showcased distinct trajectories in their Selling, General, and Administrative (SG&A) expenses.
From 2014 to 2023, Vertex Pharmaceuticals saw a consistent rise in SG&A expenses, growing by approximately 272%. This upward trend reflects the company's strategic investments in marketing and administrative capabilities, crucial for maintaining its competitive edge in the biotech sector.
Zoetis Inc., a leader in animal health, maintained a robust SG&A expenditure, with a 31% increase over the same period. By 2023, Zoetis's expenses were nearly double those of Vertex, underscoring its expansive market reach and operational scale.
These insights highlight the strategic financial maneuvers of these pharmaceutical giants, offering a glimpse into their operational priorities and market strategies.
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Bristol-Myers Squibb Company or Zoetis Inc.: Who Manages SG&A Costs Better?
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Summit Therapeutics Inc.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Zoetis Inc. vs MannKind Corporation Trends and Insights